How big is Trupanion, Inc.?

As of Jun 18, Trupanion, Inc. has a market capitalization of 2,318.74 million and reported net sales of 0.00 million with a net profit of -4.25 million for the latest four quarters. Shareholder's funds are at 323.27 million and total assets are 806.85 million.

As of Jun 18, Trupanion, Inc. has a market capitalization of 2,318.74 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -4.25 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 323.27 million and Total Assets at 806.85 million.

What does Trupanion, Inc. do?

Trupanion, Inc. offers medical insurance plans for cats and dogs and is classified as a micro-cap company with a market cap of approximately $2.32 billion. As of March 2025, it reported a net profit of -$1 million.

Overview:<BR>Trupanion, Inc. provides medical insurance plans for cats and dogs and operates within the insurance industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 2,318.74 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 2,162.00<BR>- Debt Equity: -999,999.00<BR>- Return on Equity: 0.27%<BR>- Price to Book: 6.95<BR><BR>Contact Details:<BR>- Address: 6100 4th Ave S Ste 200, SEATTLE WA : 98108-3234<BR>- Tel: ['1 888 7387478', '1 206 6071929']<BR>- Fax: 1 302 6365454<BR>- Website: https://trupanion.com/

Should I buy, sell or hold Trupanion, Inc.?

Who are in the management team of Trupanion, Inc.?

As of March 2022, Trupanion, Inc.'s management team includes Dr. Murray Low (Independent Chairman), Mr. Darryl Rawlings (President and CEO), and several independent directors: Mr. Eric Johnson, Ms. Jacqueline Davidson, Mr. Michael Doak, Ms. Robin Ferracone, and Mr. Dan Levitan. This team combines executive leadership with independent oversight for diverse governance.

As of March 2022, the management team of Trupanion, Inc. includes the following individuals:<BR><BR>- Dr. Murray Low, who serves as the Independent Chairman of the Board.<BR>- Mr. Darryl Rawlings, who is the President, Chief Executive Officer, and a Director.<BR>- Mr. Eric Johnson, who holds the position of Director.<BR>- Ms. Jacqueline Davidson, who is an Independent Director.<BR>- Mr. Michael Doak, who is also an Independent Director.<BR>- Ms. Robin Ferracone, serving as an Independent Director.<BR>- Mr. Dan Levitan, who is another Independent Director.<BR><BR>In summary, the management team comprises a mix of executive leadership and independent directors, ensuring a diverse governance structure.

Is Trupanion, Inc. overvalued or undervalued?

As of August 7, 2025, Trupanion, Inc. is considered overvalued with a high P/E ratio of 2162 and poor stock performance, underperforming the S&P 500 significantly over the past year and five years.

As of 7 August 2025, Trupanion, Inc. has moved from a risky to an expensive valuation grade. The company appears to be overvalued, given its high P/E ratio of 2162, a Price to Book Value of 6.48, and an EV to EBITDA of 119.55. In comparison, peers such as AXIS Capital Holdings Ltd. and MGIC Investment Corp. have much lower P/E ratios of 18.60 and 10.15, respectively, indicating that Trupanion is trading at a significant premium relative to its industry counterparts.<BR><BR>The stock has underperformed against the S&P 500 across multiple time frames, with a 1-year return of -2.18% compared to the S&P 500's 17.14%, and a staggering 5-year return of -35.37% against the index's 96.61%. This performance further supports the notion that Trupanion is overvalued in the current market environment.

Is Trupanion, Inc. technically bullish or bearish?

As of October 31, 2025, Trupanion, Inc. is in a bearish trend with weak strength indicators, significantly underperforming the S&P 500 with year-to-date returns of -18.28% compared to 16.30%.

As of 31 October 2025, the technical trend for Trupanion, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD and Bollinger Bands both showing bearish signals, while the monthly MACD is only mildly bullish. The RSI is bearish on a monthly basis, and moving averages are bearish on a daily basis. Additionally, the KST and Dow Theory are both bearish on a weekly basis. <BR><BR>Trupanion's performance has significantly lagged behind the S&P 500, with a year-to-date return of -18.28% compared to the S&P 500's 16.30%, and a one-year return of -27.80% versus 19.89% for the index.